Physician

Scott E Bingham, MD

According to 2025 Medicare claims, Scott Bingham, MD (NPI: 1487612214) practices interventional cardiology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is REVERE HEALTH PC (NPI: 1093764805; TIN: 870281028) and primary practice location at 84604-3305. Bingham is affiliated with the Aledade 201 National MSSP (ACO ID: A5522) and Revere Health Collaborative Network, LLC (ACO ID: D0042), participating under both the MSSP and REACH models.

Bingham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,560 traditional Medicare patients, billed 45,296 HCPCS/CPT codes, and received $370,026 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 10,077 prescription claims across 1,135 beneficiaries totaling $1,034,634 in drug costs, led by Eliquis (Apixaban). DME data shows 40 claims. Open Payments data shows 12 records totaling $224. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $225,896 to $1,034,634. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $7,012 and ending at $4,549.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,088	14,588	$411,883
2016	2,178	13,135	$342,489
2017	1,927	11,598	$303,262
2018	2,166	25,008	$313,115
2019	2,046	31,309	$334,875
2020	1,689	25,839	$357,987
2021	1,929	23,971	$430,985
2022	1,731	19,444	$365,421
2023	1,834	26,272	$413,596
2024	1,560	45,296	$370,026

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	975	6,230	$225,896
2016	961	5,576	$204,021
2017	892	4,991	$206,405
2018	939	5,457	$274,817
2019	1,068	5,865	$361,649
2020	1,197	6,539	$432,712
2021	1,303	9,391	$784,964
2022	1,250	10,000	$808,538
2023	1,193	10,003	$953,876
2024	1,135	10,077	$1,034,634

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	58	$6,303
2016	N/R	26	$2,405
2017	N/R	30	$1,678
2018	N/R	28	$1,492
2019	N/R	23	$1,157
2020	N/R	35	$2,725
2021	12	91	$7,657
2022	N/R	28	$2,258
2023	N/R	40	$4,479
2024	N/R	40	$3,975

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	379	384	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	574	700	$84
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	537	649	$11
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	180	183	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	159	201	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	471	27,817	$526,390
Xarelto	Rivaroxaban	145	11,194	$204,967
Jardiance	Empagliflozin	71	3,630	$67,974
Entresto	Sacubitril/Valsartan	80	4,365	$61,640
Atorvastatin Calcium	Atorvastatin Calcium	1,975	163,986	$26,437

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	40	$3,975

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$224	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Scott E. Bingham, MD?

Tedicare shows public-source Medicare data for Scott E. Bingham, MD (NPI 1487612214), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott E. Bingham, MD have ACO affiliation data?

Scott E. Bingham, MD is shown with ACO affiliation data for Aledade 201 National MSSP (MSSP, ACO ID A5522) and Revere Health Collaborative Network, LLC (REACH, ACO ID D0042).

What billing organization is linked to Scott E. Bingham, MD?

Scott E. Bingham, MD is linked to REVERE HEALTH PC (billing NPI 1093764805) in the available physician profile data.

Does Scott E. Bingham, MD have Open Payments data?

Scott E. Bingham, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.